FMO5 and chronic granulomatous disease: When using the optimal protocol in CD34+ HPSCs from a p67phox-deficient CGD patient, we achieved the predicted frequency of gene insertion and the rescue of NADPH oxidase activity to normal levels with a considerable reduction of AAV.